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The production of prostaglandin EZ (PGE2) by cultured dog thyroid cells was high in a serum-containing 
medium and low in a serum-free, completely defined medium. Thyrotropin (TSH) and epidermal growth 
factor (EGF), two mitogenic factors for these cells, did not stimulate PGE2 release. Indomethacin, at a 
concentration which completely inhibited PGE2 production, had no effect on thyroid cell multiplication 
and DNA synthesis stimulated by TSH and EGF. It is concluded that cyclooxygenase products are not 
involved in the proliferation of canine thyroid cells and its control by TSH. 
Thyroid Thyrotropin EGF Prostaglandin Indomethacin Proliferation 
Serum-free culture 
1. INTRODUCTION 
Prostaglandin (PG)Fh initiates DNA synthesis 
and cell proliferation in 3T3 fibroblast cultures [ 11. 
This mitogenic action is synergistically enhanced 
by prostaglandin (PG) El or EZ [2]. Prostaglandin 
production has been suggested to have a mediator 
role in the stimulation of proliferation by various 
growth factors or tumor promoters [3-71. In vivo 
and in vitro experiments have suggested that pro- 
staglandins might play a role in the mitogenic ac- 
tion of thyrotropin (TSH) on the thyroid gland. 
Authors in [8] have observed that prostaglandin 
synthesis inhibitors abolished the stimulatory ef-’ 
.fect of TSH on rat thyroid cell multiplication in 
vivo. In [9] it was reported that indomethacin and 
aspirin inhibit the mitogenic effect of TSH on a 
cloned cell line derived from the rat thyroid. In ad- 
dition, a chronic stimulatory effect of TSH on rat 
thyroid prostaglandin synthesis has been observed 
in [lo]. In order to evaluate the general validity of 
these observations, we investigated the effects of 
TSH on prostaglandin synthesis and of cycloox- 
ygenase inhibitors on the mitogenic action of TSH, 
in primary cultures of differentiated canine thyroid 
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cells [l 1,121. In this model system, TSH is suffi- 
cient to trigger the DNA synthesis and the pro- 
liferation of cells which are quiescent in serum- 
free, chemically defined culture conditions [ 121. 
2. MATERIALS AND METHODS 
2.1. Materials 
Collagenase (130 units/mg) was purchased from 
Worthington Chemical Co. (Freehold, NJ). Basal 
medium of Eagle (BME), Dulbecco’s modification 
of minimum essential medium (DMEM), Ham’s 
F12 medium, MCDB 104 medium, glutamine, 
penicillin-streptomycin and amphotericin B 
(fungizone) were obtained from Flow Labs (Ir- 
vine). Foetal calf serum was from Eurobio (Paris). 
Bovine insulin, transferrin, murine epidermal 
growth factor (EGF) were purchased from Collab. 
Res. (Waltham, MA). Glycylhistidyllysyl acetate 
and somatostatin were Sigma products (St Louis, 
MO). Bovine TSH (l-3 IU/mg) was obtained 
from Armour Pharmaceutical Co. (Chicago, IL). 
[methyl-3H]Thymidine (40 Ci/mmol) and tritium- 
labelled tracers were obtained from the 
Radiochemical Centre (Amersham). PG and TxBz 
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standards were purchased from Upjohn were incubated with TSH in the presence of 
Diagnostics (Kalamazoo, MI). Anti-PGE2 and [3H]thymidine (10 ,&i/ml, 3 x lo-’ M) and deoxy- 
anti-PGFh antisera were purchased, respectively, cytidine (10M4 M) for the indicated times. The 
from Institut Pasteur de Paris and Clinical Assays. cells in the Petri dishes were fixed by methanol, ex- 
Anti-6-keto-PGFi, and anti-TxBs antisera were tensively washed and autoradiographies were per- 
gifts from Dr J. Beetens (Antwerp) and Dr J.M. formed as in [ 131. The cells were stained with 
Smith (Philadelphia), respectively. Optifluor scin- toluidine blue and the proportion of labelled nuclei 
tillation fluid was obtained from Packard was evaluated by counting at least 500 nuclei from 
Instruments. different microscopical fields. 
2.2. Cell culture 2.4. Active transport of iodide 1141 
Dog thyroid cells were cultured as in [ 11,121. 
Briefly, the thyroid tissue was digested by col- 
lagenase so that the resulting suspension consisted 
mainly of fragmented and intact follicles. These 
follicles were seeded in 35-mm tissue culture- 
treated plastic Petri dishes, and, in 1 day, adhered 
to the substratum while a monolayer developed. 
The seeding was realized so that 5 x 104 to 2 x 10’ 
cells attached to the dish after 1 day and 1 medium 
change. Following indications, the cells were 
cultured in BME supplemented with 10% serum 
from dogs treated for 2 days with thyroid extracts 
in order to reduce the endogenous TSH level [I I], 
4% foetal calf serum, 2 mM glutamine, 100 units 
penicillin/ml, 100 fig streptomycin/ml, 2.5 pg am- 
photericin B/ml; or in a chemically defined serum- 
free medium: DMEM + Fr2 f MCDB 104 (2: 1: 1) 
supplemented by 10 pg insulin/ml, 1.25 pg 
transferrin/ml, 10 ng glycylhistidyllysyl acetate/ 
ml, 10 ng somatostatin/ml and 40 ,ug ascorbic 
acid/ml with the same glutamine and antibiotic 
supplement. The Petri dishes were maintained in a 
water-saturated incubator at 37°C in an atmos- 
phere of 5% CO2 in air. The medium was renewed 
every other day and TSH or other effecters were 
added as indicated. 
The trapping of iodide was evaluated by the up- 
take of radioiodide at equilibrium. The cells in the 
Petri dishes were incubated for 2 h with Na13’I 
(2 &i/ml) in 10e6 M KI in BME at 37°C. Mercap- 
tomethylimidazole (1 mM) was added to block 
iodide organification. The cells were then rapidly 
rinsed with BME 3 times, scraped and counted in 
a y-counter. The radioactivity was normalized to 
the cellular DNA measured from the same dishes. 
2.5. Prostaglandin assays 
The radioimmunoassay of PGE2, PGFh, 
6-keto-PGFi, and thromboxane BZ released by the 
cells was performed as in [15]. The specificity of 
antisera used was reported in [ 151. The following 
criteria of validity for these assays were fulfilled: 
good interassay reproducibility (c.v. = 5% for 10 
serial measurements over one month), good cor- 
relation between values obtained at two different 
dilutions of the samples (r = 0.92) and complete in- 
hibition by indomethacin of the release of im- 
munoreactive material. The concentration of 
PGEz in dog serum was 6.5 + 2.0 ng/ml (mean f 
SD; n = 6). All the results were corrected by sub- 
tracting the amount of PGEz present in the culture 
medium. 
2.3. Proliferation assays 
Cell multiplication curves were obtained from 
cell DNA measurements. Our cell DNA assay 
described in [l l] uses the increase of fluorescence 
of ethidium bromide when complexed with nucleic 
acids. It has been verified that an increase in cell 
DNA amount per dish reflects an increase in cell 
number. 
3. RESULTS 
DNA synthesis was evaluated by the frequency 
of the [3H]thymidine-labelled nuclei as estimated 
by autoradiography [12]. The quiescent cells, after 
4-day culture in the chemically defined medium, 
Dog thyroid cells, cultured in the presence of 
serum, released large amounts of PGEz in the 
culture medium (fig.1). During the first 24-h 
period, starting one day after seeding, the output 
of PGEz was 19 f 3 ng/pg DNA (mean +- SE, 9 ex- 
periments): this represents about 96 + 17 ng/106 
cells, on the basis of a nuclear content of DNA 
equal to 5 pg. PGE;? production gradually declined 
during the following days (fig.1). TSH (10 
munits/ml), which stimulated the proliferation of 
137 
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0-I l-3 3-5 5-7 7-10 days 
Fig.1. Kinetics of PGE2 release by dog thyroid cells 
cultured in a serum-containing medium (BME + 10% 
dog serum and 4% foetal calf serum). PGE2 was 
measured in the medium in which thyroid cells grew for 
the indicated periods. Results are expressed as the 
mean + range of measurements on duplicate dishes in 1 
representative xperiment out of 9. 
these cells, did not increase their release of PGEz 
(fig.1). In most experiments, TSH produced a 
significant inhibition of this release: during the 
first 24-h period, TSH-treated cells released 30 + 
4% less PGEz than control cells (mean + SE, 9 ex- 
periments; range: 4-39070). When canine thyroid 
cells were cultured in a serum-free completely 
defined medium, they released much lower 
amounts of PGE2 (fig.2). This release declined 
with time and was stimulated neither by TSH, nor 
by Epidermal Growth Factor (EGF), which were 
both mitogenic for these cells ([16], submitted) 
(fig.2). The thyroid cells produced amounts of 
6-keto-PGFi, similar to those of PGE2 and lower 
quantities of PGFb,, whereas TxB2 was below the 
detection limit. The release of 6-keto-PGFi, and 
PGFh was characterized by the same temporal 
pattern and lack of stimulation by TSH, as PGEz 
release (not shown). 
Indomethacin, at a concentration of 0.56 PM or 
1.4 pM which completely inhibited the production 
of PGE2 (table I), had no effect on the multiplica- 
tion of canine thyroid cells measured either in a 
serum-containing medium or in a serum-free com- 
pletely defined medium. The stimulatory effect of 
TSH or of the TSH-EGF combination on thyroid 
TSH (ImUiml) 
TSH (ImU/ml~tEGF~25ng/ml~ 
l-2 2-4 4-6 6-8 days 
Fig.2. Kinetics of PGE2 release by dog thyroid cells 
cultured in a serum-free, completely defined medium. 
TSH or EGF were added at day 1 and their presence 
maintained in the culture medium which was renewed 
every other day. Results are expressed as the mean * SD 
of 4 determinations (duplicate dishes in 2 separate 
experiments). 
cell multiplication (fig.3) and DNA synthesis (table 
1) was not altered by indomethacin. The enhance- 
ment of iodide uptake by TSH was also insensitive 
to indomethacin (table 1). 
4. DISCUSSION 
The amount of PGE2 produced by the dog 
,TSH+EGF 
0 
x 2_ 1 
12 4 6 8 days 
Fig.3. Lack of effect of indomethacin on the 
multiplication of dog thyroid cells stimulated by a 
combination of TSH and EGF. TSH (1 munit/ml) and 
EGF (25 ng/ml) were added to control medium at day 1 
and their presence maintained throughout the culture 
period, while medium was renewed every other day. 
Indomethacin (1.4 PM) was present from the seeding 
time (day 0). Results are expressed as the mean + range 
of measurements on duplicate dishes. 
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Table 1 
January 1984 
Effect of indomethacin on labelling of nuclei by [3H]thymidine, iodide uptake and PGE2 release in dog thyroid cells 
cultured in a defined serum-free medium 
Labelled nuclei Iodide uptake PGEz release 
(Q) (cpm i311/ng DNA) (ng/pg DNA per 24 h) 
Control 2.2 f 0.5 5.4 f 0.4 0.23 + 0.03 
TSH (1 munits/ml) 54.1 + 0.8 43.4 + 1.0 0.17 f 0.05 
Indomethacin (1.4 ,uM) 1.6 + 0.2 5.6 f 0.6 < 0.02 
TSH (1 munit/ml) + 
indomethacin (1.4 PM) 52.6 + 0.3 38.7 + 1.3 < 0.02 
The cells were seeded and cultured for 4 days in the complete control serum-free medium, with or without indomethacin 
(1.4pM). At day 4, TSH (1 munit/ml) was added to cells cultured in the presence or in the absence of indomethacin 
and the presence of the effecters was maintained for the rest of the culture. DNA synthesis was evaluated by the 
accumulation of [3H]thymidine-labelled nuclei between day 5 and day 6, revealed by autoradiography. Iodide uptake 
was estimated 48 h after TSH addition. PGE2 accumulation i the medium was estimated for a 56-h period starting 
at day 4. Results are expressed as the mean + range of measurements on duplicate dishes 
thyroid cells was critically dependent on the culture 
conditions: cells cultured in a defined medium 
released IO-30 times less PGEz than cells cultured 
in a serum-containing medium. Serum is a well 
known stimulus of prostaglandin synthesis in cell 
culture [17,18]. 
TSH did not stimulate the release of PGEz, 
6-keto-PGFr,, PGFk or thromboxane B2 by 
cultured dog thyroid cells. In most experiments 
performed in serum-containing medium, PGE2 
output was significantly decreased by TSH. TSH 
has also been shown to inhibit PGE2 production by 
non-growing cultures of dog thyroid cells [19,20]. 
The chronic stimulatory effect of TSH on rat 
thyroid prostaglandin synthesis observed in vivo 
[IO] has thus not been reproduced in this in vitro 
model of chronic stimulation by TSH. The lack of 
stimulatory effect of TSH on PGEz production by 
thyroid cells is in contrast with the delayed stimula- 
tion of prostaglandin synthesis in graafian follicles 
by LH and HCG, which share with TSH a similar 
glycoprotein structure and a common mediator, 
cyclic AMP [21,22]. EGF increases prostaglandin 
synthesis in some cell cultures [3]; on the contrary, 
in dog thyroid cells, it produced a mitogenic 
response but no stimulation of PGEz release. 
Indomethacin, at a concentration which com- 
pletely inhibited PGE2 production by the thyroid 
cells, did not depress the basal proliferation 
stimulated by serum and the mitogenic effects of 
TSH and EGF, isolated or in combination, 
evaluated as cell multiplication (measurement of 
DNA content). The triggering by TSH of DNA 
synthesis by quiescent cells in serum-free condi- 
tions was not affected by indomethacin. 
On the other hand, we have failed to detect any 
mitogenic effect of exogenously added pro- 
staglandins E (l-3 pg/ml) or Fz~ (1 pug/ml) both in 
high serum or serum-free conditions (unpublish- 
ed). The discrepancy between our results and those 
in [9] on a rat thyroid cell line, might be due to a 
species difference, but might be also inherent to 
the experimental system used: in our hands, 
primary culture of cells, which have little pro- 
liferated in vitro in defined conditions before TSH 
addition, may not be suspected to be genetically 
transformed or selected by their culture condi- 
tions. In contrast, the rat thyroid cell line FRTL 5 
has been selected by cloning from the FRTL cells 
in order to be quiescent in the presence of 5% 
serum and mitogenically stimulated by TSH [23]. 
The parental FRTL line itself appears actually im- 
mortal and is cloned and propagated in the con- 
tinuous presence of TSH. TSH is not only required 
for the proliferation, but also for the survival of 
these cells [24]. Such lines may have developed new 
mechanisms of growth control or be submitted to 
new rate controlling effecters, the general 
relevance of which is questionable. 
In conclusion, our study shows that in primary 
cultures of dog thyroid cells, TSH and EGF do not 
stimulate prostaglandin production and in- 
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domethacin does not inhibit their mitogenic ac- 
tion. This is true whatever the culture conditions 
used: either in a serum-containing medium or in a 
serum-free, completely defined medium. The inter- 
pretation of the results obtained in a completely 
defined medium is straightforward, since it is not 
complicated by the presence of prostaglandins con- 
tained in serum. It can thus be stated that 
cyclooxygenase products are not necessary for the 
expression of the mitogenic response to TSH (or to 
EGF) in dog thyroid cells in primary culture. The 
trapping of iodide and its stimulation by TSH, a 
marker of the differentiated state of these cells, is 
also independent of cyclooxygenase products. 
These findings are consistent with the view that 
cyclic AMP is a sufficient signal to mediate the 
stimulatory effect of TSH on both the differen- 
tiated functions and the proliferation of thyroid 
cells [ 121. 
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